Alzamend Neuro Inc (ALZN)

Alzamend Neuro Inc (ALZN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $6.5M; returns 1 day +0.9%, 1 week -13.1%, 1 year -51.5%.

Alzamend Neuro Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for neurodegenerative diseases and psychiatric disorders. The company currently generates no revenue from product sales, and its business model is entirely dependent on raising capital through equity and debt financing to fund its research and development pipeline.

Groups ALZN belongs to

• Clinical Stage Biopharma
• Alzheimer's Disease
• Biotechnology
• CNS Disorders
• Biopharmaceutical
• Neuroscience
• Clinical Stage Biotech
• Neurological Disorders
• Healthcare

ALZN financial model: income statement, cash flow and balance sheet